References
- Agarwal MM, Boulvain M, Coetzee E, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2013;103(3):341–363.
- Lorenzo-Almoros A, Hang T, Peiro C, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140.
- Elvebakk T, Mostad IL, Morkved S, et al. Dietary intakes and dietary quality during pregnancy in women with and without gestational diabetes mellitus – a Norwegian longitudinal study. Nutrients. 2018;10(11):1811.
- Martin-Montalvo A, Lopez-Noriega L, Jimenez-Moreno C, et al. Transient PAX8 expression in islets during pregnancy correlates with beta-cell survival, revealing a novel candidate gene in gestational diabetes mellitus. Diabetes. 2019;68(1):109–118.
- Alldred SK, Takwoingi Y, Guo B, et al. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening. Cochrane Database Syst Rev. 2017;3:D12600.
- Palomaki GE, Bupp C, Gregg AR, et al.; on behalf of the ACMG Biochemical Genetics Subcommittee ofthe Laboratory Quality Assurance Committee. Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020;22(3):462–474.
- Visconti F, Quaresima P, Chiefari E, et al. First Trimester Combined Test (FTCT) as a predictor of gestational diabetes mellitus. Int J Environ Res Public Health. 2019;16(19):E3654.
- Donovan BM, Nidey NL, Jasper EA, et al. First trimester prenatal screening biomarkers and gestational diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2018;13(7):e201319.
- Xiao D, Chenhong W, Yanbin X, et al. Gestational diabetes mellitus and first trimester pregnancy-associated plasma protein A: a case-control study in a Chinese population. J Diabetes Investig. 2018;9(1):204–210.
- Bestwick JP, Huttly WJ, Wald NJ. Distribution of nuchal translucency in antenatal screening for Down’s syndrome. J Med Screen. 2010;17(1):8–12.
- Bestwick JP, Huttly WJ, Wald NJ. The estimation of median nuchal translucency values between 10 and 14 weeks of pregnancy. J Med Screen. 2014;21(2):110–112.
- Santorum M, Wright D, Syngelaki A, et al. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol. 2017;49(6):714–720.
- Chen Y, Zhang W, Lu S, et al. Maternal serum alpha fetoprotein and free beta-hCG of second trimester for screening of fetal gastroschisis and omphalocele. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017;46(3):268–273.
- Sprawka N, Lambert-Messerlian G, Palomaki GE, Eklund EE, et al. Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes. Prenat Diagn. 2011;31(3):282–285.
- Bredaki FE, Wright D, Akolekar R, et al. Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks’ gestation. Fetal Diagn Ther. 2011;30(4):274–279.
- Sweeting AN, Wong J, Appelblom H, et al. A novel early pregnancy risk prediction model for gestational diabetes mellitus. Fetal Diagn Ther. 2019;45(2):76–84.
- Talasaz ZH, Sadeghi R, Askari F, et al. First trimesters pregnancy-associated plasma protein-A levels value to predict gestational diabetes mellitus: a systematic review and meta-analysis of the literature. Taiwan J Obstet Gynecol. 2018;57(2):181–189.
- Caliskan R, Atis A, Aydin Y, et al. Huseyin Kiyak, Fitnat Topbas. PAPP-A concentrations change in patients with gestational diabetes. J Obstet Gynaecol. 2020;40(2):190–194.
- Li Y, Ren X, He L, et al. Maternal age and the risk of gestational diabetes mellitus: a systematic review and meta-analysis of over 120 million participants. Diabetes Res Clin Pract. 2020;162:108044.
- Alsaedi SA, Altalhi AA, Nabrawi MF, et al. Prevalence and risk factors of gestational diabetes mellitus among pregnant patients visiting National Guard primary health care centers in Saudi Arabia. SMJ. 2020;41(2):144–150.
- Alves JG, Souza ASR, Figueiroa JN, et al. Visceral adipose tissue depth in early pregnancy and gestational diabetes mellitus – a cohort study. Sci Rep. 2020;10(1):2032.
- Lappas M. Effect of pre-existing maternal obesity, gestationaldiabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue. Metabolism. 2014;63(2):250–262.